학술논문
A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway
Document Type
Article
Author
Source
In: Acta Pharmaceutica Sinica B . (Acta Pharmaceutica Sinica B, March 2023, 13(3):1093-1109)
Subject
Language
English
ISSN
22113843
22113835
22113835